应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EFTR Effector Therapeutics, Inc.
耶稣受难日休市 03-28 16:00:00 EDT
14.39
+0.94
+6.99%
盘后
14.39
+0.00
0.00%
19:48 EDT
最高
14.72
最低
13.25
成交量
35.17万
今开
13.25
昨收
13.45
日振幅
10.93%
总市值
5,306万
流通市值
5,139万
总股本
368.73万
成交额
497.83万
换手率
9.85%
流通股本
357.13万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
eFFECTOR Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要
Reuters · 03-26
eFFECTOR Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要
Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.19%
自选股智能写手 · 03-25
Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.19%
Effector Therapeutics, Inc.盘中异动 早盘快速下跌5.45%
自选股智能写手 · 03-22
Effector Therapeutics, Inc.盘中异动 早盘快速下跌5.45%
Effector Therapeutics, Inc.盘中异动 快速拉升5.42%
自选股智能写手 · 03-18
Effector Therapeutics, Inc.盘中异动 快速拉升5.42%
Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.37%
自选股智能写手 · 03-04
Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.37%
Effector Therapeutics, Inc.盘中异动 急速上涨5.19%报15.19美元
自选股智能写手 · 03-02
Effector Therapeutics, Inc.盘中异动 急速上涨5.19%报15.19美元
Effector Therapeutics Inc盘中异动 大幅拉升5.42%报12.25美元
自选股智能写手 · 02-27
Effector Therapeutics Inc盘中异动 大幅拉升5.42%报12.25美元
Effector Therapeutics Inc盘中异动 急速跳水5.14%
自选股智能写手 · 02-02
Effector Therapeutics Inc盘中异动 急速跳水5.14%
Effector Therapeutics Inc盘中异动 早盘快速跳水5.38%
自选股智能写手 · 01-31
Effector Therapeutics Inc盘中异动 早盘快速跳水5.38%
Effector Therapeutics Inc盘中异动 大幅拉升5.15%报9.55美元
自选股智能写手 · 01-26
Effector Therapeutics Inc盘中异动 大幅拉升5.15%报9.55美元
加载更多
公司概况
公司名称:
Effector Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
eFFECTOR Therapeutics, Inc.是一家于2020年10月2日在特拉华州注册成立的公司。eFFECTOR是一家临床阶段的生物制药公司,专注于开拓一类被称为选择性翻译调节剂抑制剂(STRIs)的新型肿瘤药物的开发。
发行价格:
--
{"stockData":{"symbol":"EFTR","market":"US","secType":"STK","nameCN":"Effector Therapeutics, Inc.","latestPrice":14.39,"timestamp":1711656000000,"preClose":13.45,"halted":0,"volume":351712,"hourTrading":{"tag":"盘后","latestPrice":14.39,"preClose":14.39,"latestTime":"19:48 EDT","volume":3166,"amount":45287.7,"timestamp":1711669699264},"delay":0,"floatShares":3571300,"shares":3687309,"eps":-18.584576,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":0.94,"latestTime":"03-28 16:00:00 EDT","open":13.25,"high":14.72,"low":13.25,"amount":4978309.614272,"amplitude":0.109294,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.584576,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"adjPreClose":13.45,"preHourTrading":{"tag":"盘前","latestPrice":13.1,"preClose":13.45,"latestTime":"09:23 EDT","volume":730,"amount":9809.82541,"timestamp":1711632208724},"postHourTrading":{"tag":"盘后","latestPrice":14.39,"preClose":14.39,"latestTime":"19:48 EDT","volume":3166,"amount":45287.7,"timestamp":1711669699264},"volumeRatio":1.4545813919176251},"requestUrl":"/m/hq/s/EFTR","defaultTab":"news","newsList":[{"id":"2422718455","title":"eFFECTOR Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2422718455","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422718455?lang=zh_cn&edition=full","pubTime":"2024-03-26 05:15","pubTimestamp":1711401308,"startTime":"0","endTime":"0","summary":" * eFFECTOR Therapeutics Inc 报告,截至12月底的季度调整后每股亏损3.42美元,高于去年同期的每股收益5.50美元。两位分析师对该季度的平均预期是每股亏损 1.65 美元。华尔街预期为每股亏损 3.21 美元至-9 美分。* eFFECTOR Therapeutics Inc 公布的季度每股收益为亏损 3.42 美元。* 该公司当季亏损 913 万美元。* eFFECTOR Therapeutics Inc 的股价本季度上涨了 5.5%。华尔街对 eFFECTOR Therapeutics Inc 的 12 个月目标价中位数为 22.50 美元。本摘要由 LSEG 3 月 25 日 09:15 p.m. UTC 的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422184548","title":"Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422184548","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422184548?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:30","pubTimestamp":1711373448,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时30分,Effector Therapeutics, Inc.股票出现异动,股价大幅上涨5.19%。Effector Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Effector Therapeutics, Inc.公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521304887e7b76d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521304887e7b76d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421819031","title":"Effector Therapeutics, Inc.盘中异动 早盘快速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421819031","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421819031?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:37","pubTimestamp":1711114626,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时37分,Effector Therapeutics, Inc.股票出现异动,股价大幅下跌5.45%。Effector Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Effector Therapeutics, Inc.公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221370687e7b0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221370687e7b0e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420471719","title":"Effector Therapeutics, Inc.盘中异动 快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420471719","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420471719?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:33","pubTimestamp":1710768798,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时33分,Effector Therapeutics, Inc.股票出现异动,股价急速上涨5.42%。Effector Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Effector Therapeutics, Inc.公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213318861df185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213318861df185&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416141067","title":"Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416141067","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416141067?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:32","pubTimestamp":1709562753,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时32分,Effector Therapeutics, Inc.股票出现异动,股价急速拉升5.37%。Effector Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。其相关个股中,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Gri Bio, Inc.较为活跃,换手率分别为1016.35%、135.12%、44.20%,振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Akero Therapeutics, Inc.,振幅分别为31.40%、27.12%、10.43%。Effector Therapeutics, Inc.公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030422323387e75ab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030422323387e75ab1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416628429","title":"Effector Therapeutics, Inc.盘中异动 急速上涨5.19%报15.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416628429","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416628429?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:05","pubTimestamp":1709309117,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日00时05分,Effector Therapeutics, Inc.股票出现异动,股价大幅上涨5.19%。Effector Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.48%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为3599.82%、387.80%、312.18%,振幅较大的相关个股有Biovie Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.,振幅分别为96.77%、81.48%、81.19%。Effector Therapeutics, Inc.公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302000517791662a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302000517791662a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414803504","title":"Effector Therapeutics Inc盘中异动 大幅拉升5.42%报12.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414803504","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414803504?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:41","pubTimestamp":1709044885,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时41分,Effector Therapeutics Inc股票出现异动,股价大幅拉升5.42%。截至发稿,该股报12.25美元/股,成交量3.8993万股,换手率1.14%,振幅4.56%。Effector Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.81%。Effector Therapeutics Inc公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722412787e739e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722412787e739e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408806389","title":"Effector Therapeutics Inc盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408806389","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408806389?lang=zh_cn&edition=full","pubTime":"2024-02-02 22:47","pubTimestamp":1706885256,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日22时47分,Effector Therapeutics Inc股票出现异动,股价快速下跌5.14%。Effector Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.75%。Effector Therapeutics Inc公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202224736790ea39a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202224736790ea39a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407644383","title":"Effector Therapeutics Inc盘中异动 早盘快速跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407644383","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407644383?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:05","pubTimestamp":1706630752,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日00时05分,Effector Therapeutics Inc股票出现异动,股价急速下跌5.38%。Effector Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.38%。其相关个股中,Neximmune Inc、Pepgen Inc、Psyence Biomedical Ltd涨幅较大,Neximmune Inc、Panbela Therapeutics Inc、Iterum Therapeutics Plc较为活跃,换手率分别为791.42%、217.69%、163.41%,振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Pepgen Inc,振幅分别为800.00%、150.22%、61.72%。Effector Therapeutics Inc公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310005527a3fbb69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310005527a3fbb69&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406794554","title":"Effector Therapeutics Inc盘中异动 大幅拉升5.15%报9.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406794554","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406794554?lang=zh_cn&edition=full","pubTime":"2024-01-26 23:12","pubTimestamp":1706281967,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日23时12分,Effector Therapeutics Inc股票出现波动,股价大幅上涨5.15%。截至发稿,该股报9.55美元/股,成交量1.9753万股,换手率0.66%,振幅4.07%。Effector Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.05%。Effector Therapeutics Inc公司简介:eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司,专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012623124787e69025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012623124787e69025&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.effector.com","stockEarnings":[{"period":"1week","weight":0.1112},{"period":"1month","weight":0.0951},{"period":"3month","weight":0.2315},{"period":"6month","weight":-0.0405},{"period":"1year","weight":0.6119},{"period":"ytd","weight":0.2315}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"eFFECTOR Therapeutics, Inc.是一家于2020年10月2日在特拉华州注册成立的公司。eFFECTOR是一家临床阶段的生物制药公司,专注于开拓一类被称为选择性翻译调节剂抑制剂(STRIs)的新型肿瘤药物的开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.04536},{"month":2,"riseRate":0.333333,"avgChangeRate":0.017635},{"month":3,"riseRate":0,"avgChangeRate":-0.144383},{"month":4,"riseRate":0.666667,"avgChangeRate":0.056081},{"month":5,"riseRate":0.666667,"avgChangeRate":0.209804},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.147592},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.151827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.075004},{"month":9,"riseRate":0.333333,"avgChangeRate":0.009481},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.10595},{"month":11,"riseRate":0,"avgChangeRate":-0.224652},{"month":12,"riseRate":0.666667,"avgChangeRate":0.05272}],"exchange":"NASDAQ","name":"Effector Therapeutics, Inc.","nameEN":"Effector Therapeutics, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Effector Therapeutics, Inc.(EFTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Effector Therapeutics, Inc.(EFTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Effector Therapeutics, Inc.,EFTR,Effector Therapeutics, Inc.股票,Effector Therapeutics, Inc.股票老虎,Effector Therapeutics, Inc.股票老虎国际,Effector Therapeutics, Inc.行情,Effector Therapeutics, Inc.股票行情,Effector Therapeutics, Inc.股价,Effector Therapeutics, Inc.股市,Effector Therapeutics, Inc.股票价格,Effector Therapeutics, Inc.股票交易,Effector Therapeutics, Inc.股票购买,Effector Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Effector Therapeutics, Inc.(EFTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Effector Therapeutics, Inc.(EFTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}